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Abstract
Objectives
We examined the effect of ‘labels’ versus ‘descriptions’ across four asymptomatic health
conditions: pre-diabetes, pre-hypertension, mild hyperlipidaemia, and chronic kidney dis-
ease stage 3A, on participants’ intentions to pursue further tests. There were four secondary
objectives: 1) assessing confidence and satisfaction in their intention to test further; 2)
revealing psychological drivers affecting intentions; 3) exploring whether intentions, confi-
dence and satisfaction differ by label vs. description and health condition; and 4) producing
a perceptual map of illnesses by label condition.
Methods
Practitioner validated health-related scenarios were used. Two variants of each condition
were developed. Participants were recruited through Qualtrics from Australia, Ireland and
Canada and randomly assigned two ‘labelled’ or two ‘descriptive’ scenarios.
Results
There was no significant difference in intentions to test between label and description condi-
tions (95% CI -0.76 to 0.33 points, p = 0.4). Confidence and satisfaction were both positively
associated with intentions: regression coefficient (β) for confidence β = 0.58 points (95% CI
0.49 to 0.68, p < .001) and for satisfaction 0.67 points (95% CI 0.57 to 0.77, p < .001). Pre-
disposition to seek healthcare (β = 0.72; 95% CI 0.47 to 0.98), attributing illness to bad luck
(β = -0.16 points; 95% CI -0.3 to -0.02), and concern about the health condition (β = 0.51;
95% CI 0.38 to 0.65) also significantly predicted intentions.
Conclusions
Unlike studies investigating symptomatic illnesses, the disease label effect on behavioural
intentions was not supported suggesting that reducing demand for medical services for
borderline cases cannot be achieved by labelling. The average intention to test score was
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higher in this sample than previous symptomatic health-related studies and there was a
positive relationship between increased intentions and confidence/satisfaction in one’s
decision. Exploratory insights suggested perceptions of the four labelled asymptomatic ill-
nesses all shifted toward greater levels of dread and concern compared to their respective
description condition.
Trial registration
ACTRN12618000392268.
Introduction
How and what are communicated between health care providers and consumers has ramifica-
tions. Much research has shown that how information–medical or otherwise–is presented to a
decision maker profoundly affects their decision making [1–4]. Continuing the line of research
by scholars such as Scherer et al. [5], Copp et al. [6] and Nickel et al. [7], we examined the effects
of including versus excluding the health condition name (e.g., informing the patient that they
might have ‘pre-diabetes’ versus ‘a slight elevation in your blood sugar level’) on decision mak-
ing and explored how individual characteristics may impact these decisions.
Unlike prior research that studied symptomatic illnesses [5–7], we focused on four
asymptomatic health conditions: pre-diabetes, pre-hypertension, mild hyperlipidaemia,
and chronic kidney disease stage 3A (CKD 3A). Each has been the focus of controversy due
to diagnostic threshold changes and the potential of overdiagnosis [8–11]. Widening disease
definitions and reducing thresholds narrows the divide between being considered healthy
or unwell, and ultimately increases the number of individuals classified as abnormal [12].
Therefore, how we communicate test results close to these thresholds may be important as
it could affect patient’s psychological states (such as increasing or decreasing anxiety) as well
as impose increased demands on the healthcare system (pursuing questionable further tests/
interventions).
Previous research suggests using medical labels to describe health conditions increases individ-
uals’ intentions to pursue further treatment [7]. For example, Scherer et al. [5] showed that pro-
viding the name of a commonly occurring child health condition (gastroesophageal reflux disease
[GERD]) to mothers rather than simply describing the symptoms interacted with the reported
efficacy of medication. Disconcertingly, compared with the symptom description group, mothers
who were given the scenario informing them of the name of the condition (GERD) indicated that
they would be more likely to seek medicative treatment even when informed of the medication’s
ineffectiveness. Similarly, Copp et al. [6] found that the presence versus absence of a health condi-
tion label (polycystic ovary syndrome [PCOS] versus hormonal imbalance) in their hypothetical
scenario study affected the likelihood of an individual wanting an ultrasound. In the presence
of the PCOS label, participants reported that they would be more likely to have an ultrasound,
thought the condition was more severe, and reported lower self-esteem compared with the symp-
tom description group. However, providing information on the potential for overdiagnosis, due
to increased sensitivity of ultrasounds, decreased participants’ intentions and perceived severity in
both groups. Recently, a systematic review [7] that included these two studies and five others con-
cluded that the presence of a health label increased the likelihood of invasive treatment, height-
ened anxiety and perceptions of illness severity compared with no label.
This study investigates whether the label effect applies to asymptomatic health conditions
where individuals are on the borderline of being classified as having these conditions. The cur-
rent study design mimics Scherer et al. [5] and Copp et al. [6] in that we too used hypothetical
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scenarios. However, four issues differentiate this research effort from preceding studies. First,
prior studies [7] examined situations where participants were provided scenarios of health
conditions with a description of symptoms the participant might experience or used scenarios
that did or did not include the word ‘cancer’. Scholars have suggested that the use of terms like
‘cancer’ should be redefined and its use circumscribed because such terms “corrupt thought”
[13]. Here, we study whether labelling asymptomatic illnesses affects intentions to pursue fur-
ther tests. This is the primary research outcome. Second, external validity was enhanced two
ways: we studied four common health conditions using samples from three countries consid-
ered broadly similar. In the absence of experiencing any symptoms, does the “labelling effect”
still hold? Third, we examined potential psychological drivers that could be affecting one’s
decision to (or not to) pursue further medical treatment. Fourth, there is some evidence that
disease labels (health condition name included) and description only scenarios affect percep-
tions of severity [6], but findings are equivocal [5]. Therefore, in addition to examining the
differences in intention to undertake further tests between labelled and description only sce-
narios (primary research objective), exploratory analysis was undertaken to see if labelling
affected perceptions of risk for each health condition.
Methods
Participants
Participants were recruited in March 2018 through Qualtrics (www.qualtrics.com). Qualtrics
uses existing, nationally representative panels of individuals who have previously agreed to
complete surveys. Participants were required to read an Explanatory Statement that included
describing the purpose of the study and that participation was voluntary, that they could dis-
continue at any time, and that names would not be collected. The survey would not advance
without all questions on each page answered, including attention check questions, hence all
returned surveys were complete. Participating in the on-line survey was accepted as informed
consent. Participants were eligible if they were 45 years or older because the health conditions
examined are more prone to afflict older adults. All participants resided in either Australia,
Canada or Ireland, countries with similar healthcare models. There were no other restrictions
to participation.
Procedure
All participants completed demographic questions and a series of psychological measures
prior to reading two health-related scenarios. Participants were then randomly assigned by
Qualtrics to read either two “labelled” or two “descriptive” hypothetical scenarios (Fig 1). Sce-
narios described the outcome of a recent health test using either the medical terms (labelled
scenario) or descriptive terms (descriptive scenario). There were “labelled” and “descriptive”
scenarios for four health conditions with controversies surrounding their threshold cut-offs
(pre-diabetes [8], pre-hypertension [9], mild hyperlipidaemia [10], and CKD 3A [11]). All sce-
narios were developed in consultation with primary health practitioners unrelated to this proj-
ect. See Appendix for scenarios and references for threshold criteria. Within each scenario,
information about the potential for overdiagnosis for the specific health condition was pro-
vided as were lifestyle behaviours known to reduce the likelihood of developing each condi-
tion. Following the scenarios, participants were asked questions on risk perception, stigma,
the likelihood of attending follow-up tests for the specific condition, and the level of their con-
fidence and satisfaction with their decision. Bond University Human Research Ethics Com-
mittee (#16123) provided ethics approval.
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Measures
The primary outcome was assessed using a single item similar to Copp et al.: “Which best
describes your intention to have the follow-up tests described in the scenario next week?” [6].
Responses ranged from 1 (definitely will not) to 10 (definitely will). With reference to their
intentions, we also asked, “How confident are you with your decision in the above scenario?”
and “How satisfied are you with your decision in the above scenario?” (1 = not at all confident
[satisfied] and 7 = very confident [satisfied]). These latter two measures allowed testing of the
first of the four secondary objectives.
Additional secondary analyses included measuring a series of potential psychological driv-
ers that could affect intentions, confidence, and satisfaction. To achieve this, perceptions of
health control were assessed using the 18-item multidimensional health locus of control, [14,
15] (MHLOC). Subscales of internal, external, and chance were created by summing related
items. Regulatory focus was assessed using the 10-item Composite Regulatory Focus Scale [16]
scored as two subscales, Promotion Focus and Prevention Focus. Responses for both scales
ranged from 1 (strongly disagree) to 6 (strongly agree) with higher scores favouring stronger
subscale influence. Individuals are predisposed to a promotion versus prevention self-regula-
tory orientation, with the latter placing relatively more emphasis on responsibilities and secu-
rity needs [17].
Participant’s self-perceptions toward their medical use was measured using the Medical
Maximizer-Minimizer Scale [18] (MMMS). Responses were averaged to form a total score.
Higher scores suggest a tendency toward more frequent health service use. The Ten Item Per-
sonality Inventory [19] (TIPI) was used to assess individual extraversion, agreeableness, con-
scientiousness, emotional stability, and openness to experience (2 items each). Items on both
MMMS and TIPI were scored on a 7-point scale ranging from 1 (strongly disagree) to 7
(strongly agree).
Fig 1. Consort flow diagram.
https://doi.org/10.1371/journal.pone.0240985.g001
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To assess risk orientation in health behaviours, we used five health/safety items described
by Weber and colleagues [20]. Response options ranged from 1 (extremely unlikely) to 5
(extremely likely).
After reading the scenario, subjects reported their perceptions of the risks associated with
the specific health condition depicted in the scenario. Risk perceptions were measured with six
items adapted from Fox-Glassman and Weber [21]. Items focused on perceptions of individual
responsibility versus bad luck, known versus unknown risks, common versus dreaded condi-
tion, immediate versus delayed risk, uncontrollable versus controllable condition, and uncon-
cerned versus concerned. Responses were rated on 7-point scales. Participants also reported
their perceptions regarding stigma associated with the conditions (comfort, embarrassment,
social isolation, and concealment) on four 7-point scales adapted from the literature [22].
Statistical analyses
Differences in intention to undertake further tests between labelled and description only sce-
narios is the primary research outcome, hence power analysis relates to this variable when data
are collapsed across the four health conditions. Copp et al. [6] reported a statistically signifi-
cant between group difference of 0.86 points in intention score, SD 2.7. For sample size calcu-
lations, we considered a more conservative 1-point difference in the 10-point future intentions
to test scale to be the smallest clinically meaningful difference. With type II error at 0.2 and sta-
tistical significance set to p = 0.05, a power calculation indicated 115 participants were needed
per group (230 total). The Power and Sample Size software (PS) was used for the calculation,
based on an independent t-test and continuous response measure [23]. To ensure equal num-
bers from each country, we aimed to recruit 240 participants (80 per country).
The primary outcome of the difference in intention scores for labelled and description-only
scenarios was analysed using mixed models linear regression rather than a simple t-test since
we had two scenario responses per person, nested within participant. Participants were fitted
as a random effect.
For secondary outcomes, we used the same regression method as above. P-values were
not adjusted for multiple comparisons. First, we report differences in satisfaction and con-
fidence in participant’s decision to undertake further tests between labelled and descrip-
tion only scenarios. Second, we conducted mixed methods regression for each of the
proposed psychological measures. Time to read and respond to the medical scenario was
also considered because time is a proxy that captures depth of information processing
[24]. Significant variables from univariate regression models (levels of significance set at p
= 0.1) were then included in multivariable regression analyses using backwards stepwise
elimination to examine the effect of participant characteristics and specific perceptions
of each health condition on an individual’s intention to pursue follow-on tests. In an
additional step, we considered the interaction of each of these variables and label versus
descriptive scenarios to assess if any of the interactions modify the effect of labelling on
intention to test. Third, we conducted an exploratory analysis of whether intentions to
pursue follow on tests as well as confidence and satisfaction differ by health condition.
These were exploratory analyses given the smaller sample sizes at the health condition
level. For all regression models, assumptions concerning linearity, homoscedasticity,
and independence and normality of residuals were checked.
Finally, also as an exploratory analysis, we produced perceptual maps of the four health condi-
tions comparing labelled and description only conditions based on participants’ responses to six
risk perception measures. Principle component analysis with varimax rotation and Kaiser nor-
malization was used to reduce dimensions. The resultant factor scores were used to generate Y
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and X coordinates on a perceptual map. Respondent factor scores were created using a regression
approach. This required two steps: 1) standardized values for the respondent’s answers to the six
risk perception measures were computed; and 2) these standardized values were then multiplied
by the values in the Component Score Coefficient Matrix. The resultant factor scores were stan-
dardized (M = 0, SD = 1). The average of the factor scores was then computed for each of the
eight conditions (label/description by four illnesses) and for each of three factors. See S2 and S3
Tables in S1 File. All data were analysed in STATA 14 and SPSS Statistics 23.
Results
Participants (N = 256) were recruited from Australia (n = 87), Ireland (n = 82), and
Canada (n = 87). Participants were aged between 45 and 82 years (Mean = 56.5 years,
SD = 8.2; Table 1) with an even gender distribution (males, 51%; females 49%). Two
labelled scenarios were randomly allocated to 129 individuals and two description only
scenarios randomly allocated to 127 participants (Fig 1). On average, participants scored
themselves 6.6/10 for overall health and relatively high on predisposition to use healthcare
(MMMS, mean = 45.8/70) agreeableness, and conscientiousness (both mean = 10.7/14).
There was no statistically significant country of origin or gender effects on intentions to
pursue further tests, nor did they improve precision, hence these potential covariates were
excluded from further analyses. Overall, participants scored similarly between groups
(Table 2 and S1 Table in S1 File).
Table 1. Participant demographics and characteristics (N = 256).
Mean / Freq SD / (%) Min Max
Age 56.5 8.2 45 82
Gender
Male 130 (50.78)
Female 126 (49.22)
Country
Australia 87 (33.98)
Canada 87 (33.98)
Ireland 82 (32.03)
Overall Health (scored /10) 6.6 1.9 1 10
MHOL (scored /36)
External 23.2 4.1 11 35
Internal 23.6 4.8 6 36
Chance 17.4 5.1 6 35
Regulatory Focus (scored /30)
Promotion 19.8 3.4 7 29
Prevention 19.1 3.3 9 29
Medical Minimizer/Maximizer Total (MMMS scored /70) 45.8 9.2 17 67
Personality (scored /14)
Extraversion 7.4 2.5 2 14
Agreeableness 10.7 2.1 3 14
Conscientiousness 10.7 2.1 4 14
Emotional Stability 9.2 2.5 2 14
Openness 9.8 2.2 2 14
Risk Orientation (scored /35) 13.7 3.8 8 24
https://doi.org/10.1371/journal.pone.0240985.t001
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Primary outcome—Differences between ‘label’ compared with ‘descriptive
only’ scenarios and intentions to test further
Individuals who read labelled scenarios scored an average of 0.22 points lower on the inten-
tions to undertake further tests measure (scale 1 to 10) than participants who read description
only scenarios, but this was not statistically significant (95% CI -0.76 to 0.33 points, p = 0.4).
This contradicts the prevailing view that there is a labelling effect [5–7]; but unlike prior stud-
ies, the focus here is on symptomatic illnesses.
Secondary outcomes
Caution should be made when interpreting our secondary outcomes as the study was powered
for the primary outcome and consequently all these outcomes are underpowered.
Differences in intention scores by health condition
After adjusting for labelled and description only and two scenarios per person, there was no
significant difference in intention scores between the four health conditions. Participants
who read scenarios suggesting pre-hyperlipidaemia (regardless of whether it was labelled or
description only), scored on average 0.37 points lower on intentions to test than individuals
who read pre-diabetes scenarios, but this difference was not statistically significant or clinically
important (Table 3). Analyses at the individual illness level are secondary outcomes and conse-
quently underpowered, and thus must be interpreted with caution.
The relationship between an individual’s intention to test and their confidence and sat-
isfaction with their decision. Confidence and satisfaction in decisions were both associated
with a higher intention to conduct further tests both overall and when adjusted for labelling.
Overall, for each point higher in confidence, participants scored 0.58 points higher in inten-
tion to test (95% CI 0.49 to 0.68, p< .001) and an increase in satisfaction was also associated
with an increase in intention scores by 0.67 points (95% CI 0.57 to 0.77, p< .001). Confidence
Table 2. Unadjusted means and standard deviations for risk perception, stigma, intention to test, confidence and
satisfaction across grouped description only and labelled scenarios.
Description only Scenarios
(n = 254)
Labelled Scenarios (n = 258)
Mean SD Mean SD
Risk Perception (score 1–7)
Responsibility vs Luck 3.2 1.3 3.2 1.3
Known vs Unknown risks 3.8 1.6 3.6 1.6
Common vs Dreaded Condition 3.1 1.3 3.4 1.5
Immediate vs Delayed risk 4.7 1.5 4.6 1.5
Uncontrollable vs Controllable Condition 5.4 1.3 5.6 1.3
Unconcerned vs Concerned 4.3 1.4 4.4 1.5
Stigma (score 1–7)
Comfort 5.3 1.5 5.5 1.4
Embarrassment 2.3 1.5 2.1 1.4
Social Isolation 2.4 1.5 2.4 1.6
Concealment 5.2 1.6 5.5 1.5
Intention to conduct future test (score 1–10) 7.3 2.3 7.1 2.7
Confidence in decision (score 1–7) 7.7 2.0 8.0 1.9
Satisfaction in decision (score 1–7) 7.9 2.0 8.1 1.9
https://doi.org/10.1371/journal.pone.0240985.t002
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and satisfaction remained significant after adjusting for labelling (0.59 points higher in inten-
tion to test for confidence, 0.67 points for satisfaction). Although statistically significant, these
differences were not more than 1 point in the intention to test scale which we deemed clinically
meaningful. There was no difference in confidence or satisfaction scores when comparing the
same health condition (e.g., pre-hypertension either labelled or pre-hypertension descriptive
only scenario) or when the specific health condition was adjusted for labelling/description
only (e.g., pre-hypertension labelled scenario compared with pre-hypertension descriptive
only scenario).
Effects of psychological characteristics, risk perceptions and stigma on intentions to
conduct further tests. To explore the effects of psychological characteristics, perceptions of
risk, stigma related to the health condition and response time, we conducted a mixed model
regression, adjusting for labelling. We also included all interactions between these variables
and label versus description only to test if labelling was an effect modifier. All main effects
are reported in Table 4. In the multivariable model, three variables contributed to predicting
an individual’s intention to conduct further tests; no interactions were significant. For every
one-point higher in an individual’s predisposition to seek health care, their intention score
increased 0.72 points (95% CI 0.47 to 0.98). The more a person considered the health condi-
tion was due to bad luck (compared with personal responsibility) their intention score
decreased by 0.16 points (95% CI -0.3 to -0.02). Finally, the more concerned (compared with
unconcerned) the individual was about the health condition, their intention to conduct fur-
ther test score increased by 0.51 points (95% CI 0.38 to 0.65).
A perceptual map of health conditions by label condition
We conducted principle component factor analyses on particpant’s responses to six risk per-
ception measures. Three dimensions emerged that were used to produce perceptual maps that
illustrate the health conditions when scenarios were labelled versus described. Three measures
loaded onto Factor 1, capturing perceptions of the condition’s dreadfulness (compared with
common), its immediacy (compared with delayed) risk and concern (compared with uncon-
cerned) about the health condition. Higher numbers indicate higher levels of these characteris-
tics. Two measures loaded onto Factor 2: whether the health condition was due to bad luck
(versus individual responsibility) and whether the risks were known or unknown. Factor 3
reflects one measure, whether the condition is controllable: higher numbers indicate that
through diligence the individual can avoid the health condition. Scores for the rotated compo-
nent matrix are reported in S2 Table in S1 File.
Fig 2 illustrates one of the three two-dimensional plots that could be created from the factor
scores. The figure illustrates the intention to test means for each of the four health conditions
(two for each condition) based on respondents’ factor scores for common condition, delayed
Table 3. The effect of labelling health conditions on an individual’s future intention to test.
Mixed models linear regression
Coeff. 95% CI p
Labelled scenario -0.22 -0.76 0.33 0.43
Condition
Pre-diabetes (reference)
Pre-hypertension 0.38 -0.41 0.48 0.87
Chronic kidney disease stage 3A 0.09 -0.37 0.54 0.71
Mild hyperlipidaemia -0.37 -0.80 0.06 0.09
https://doi.org/10.1371/journal.pone.0240985.t003
PLOS ONE Health condition labels and behavioural intentions
PLOS ONE | https://doi.org/10.1371/journal.pone.0240985 October 26, 2020 8 / 14
risk, and not concerned versus dreadful condition, immediate risk, and concerned (Factor 1,
horizontal axis) and individual responsibility and known risk versus bad luck and unknown
risk (Factor 2, vertical axis). This analysis, being at the individual health condition level rather
than the group level, is underpowered hence exploratory; nevertheless, it is interesting that
across all four health conditions the presence of the label (filled symbols) appears to induce
higher perceptions of dread than symptom only descriptions (relative to their corresponding
description condition, all had higher values on Factor 1). Also, for mild hyperlipidaemia, CKD
3A and pre-diabetes, but not pre-hypertension, there appears a move toward more responsibil-
ity and known risk when labels for the health condition are used compared with description
only scenarios (i.e., lower values on Factor 2). The factor scores by health conditions are
reported in S3 Table in S1 File.
Post hoc analyses comparing individual health conditions on intention to undertake
future tests. Additional exploratory analyses were conducted at the individual illness level
and are subsequently underpowered. Perceptions of risk differed between health conditions
and were associated with intentions to pursue further tests (Table 5). Using risk perceptions
associated with pre-diabetes as the baseline, participants who read CKD 3A scenarios had
intention to test scores 0.50 points higher (95% CI 0.17 to 0.82, p = 0.003) for each point they
Table 4. The effects of participant characteristics, risk perception and stigma to intention to test scores after adjusting for labelling.
Univariable Analyses Final Multivariable Analyses
Coeff. 95% CI p Coeff. 95% CI p
Overall Health 0.14 -0.01 0.28 0.06
MHOL
External 0.67 0.28 1.06 0.001
Internal 0.13 -0.21 0.47 0.462 - - - -
Chance -0.16 -0.48 0.16 0.332 - - - -
Regulatory Focus
Promotion 0.47 0.08 0.87 0.02
Prevention -0.06 -0.48 0.36 0.78 - - - -
Predisposition to seek health care (MMMS) 1.03 0.76 1.30 < .001 0.72 0.47 0.98 < .001
Personality
Extraversion 0.20 -0.01 0.41 0.07 - - - -
Agreeableness -0.03 -0.29 0.23 0.82 - - - -
Conscientiousness 0.19 -0.07 0.45 0.16 - - - -
Emotional Stability -0.08 -0.30 0.14 0.48 - - - -
Openness 0.14 -0.10 0.38 0.27 - - - -
Risk Orientation 0.07 -0.29 0.43 0.69 - - - -
Risk Perception
Individual responsibility vs Bad luck -0.27 -0.42 -0.11 0.001 -0.16 -0.30 -0.02 0.03
Known vs Unknown risks 0.01 -0.11 0.13 0.85 - - - -
Common vs Dreaded Condition 0.11 -0.03 0.24 0.12 - - - -
Immediate vs Delayed risk -0.36 -0.49 -0.23 < .001
Uncontrollable vs Controllable Condition 0.04 -0.13 0.21 0.63 - - - -
Unconcerned vs Concerned 0.62 0.49 0.76 < .001 0.51 0.38 0.65 < .001
Stigma
Comfort -0.02 -0.17 0.13 0.83 - - - -
Embarrassment 0.00 -0.16 0.15 0.96 - - - -
Social Isolation 0.04 -0.10 0.18 0.61 - - - -
Concealment 0.05 -0.09 0.19 0.49 - - - -
https://doi.org/10.1371/journal.pone.0240985.t004
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perceived the condition was contracted more through bad luck than personal responsibility.
However, for CKD 3A, participants had lower intention to test scores for each point they
thought the condition was controllable (compared with uncontrollable, -0.46 points 95% CI
-0.77to -0.15, p = .004). Taken together, these suggest when participants read scenarios about
CKD 3A, they score higher on intentions to test (compared with pre-diabetes) when they per-
ceived CKD 3A was contracted through bad luck, but when the CKD 3A was considered con-
trollable participants were less likely to have future tests compared with pre-diabetes.
Similarly, compared with pre-diabetes scenarios, for participants reading the pre-hypertension
scenarios intention to test scores were 0.56 points lower (95% CI -0.87 to -0.26, p< .001) for each
point they perceived the condition was controllable (compared with uncontrollable). No other
risk perception measures differed between health conditions. After adjusting for labelling, the
Fig 2. Perceptual map for risks associated with label versus descriptive diseases.
https://doi.org/10.1371/journal.pone.0240985.g002
Table 5. The effects of health condition and risk perception on intention to undertake future tests.
Pre-Hypertension Chronic Kidney Disease 3A Mild Hyperlipideamia
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
Pre Diabetes (reference)
Risk Perception
Individual responsibility vs Bad luck 0.28 -0.04 0.60 0.50� 0.17 0.82 -0.06 -0.39 0.26
Known vs Unknown risks 0.23 -0.16 0.62 0.33 -0.06 0.73 0.09 -0.31 0.48
Common vs Dreaded Condition 0.22 -0.12 0.55 0.04 -0.30 0.38 -0.30 -0.64 0.04
Immediate vs Delayed risk -0.04 -0.41 0.34 0.16 -0.22 0.53 0.32 -0.06 0.69
Uncontrollable vs Controllable Condition -0.56� -0.87 -0.26 -0.46� -0.77 -0.15 -0.14 -0.45 0.17
Unconcerned vs Concerned -0.23 -0.58 0.12 -0.84 -0.44 0.27 -0.32 -0.67 0.04
� p < 0.05
https://doi.org/10.1371/journal.pone.0240985.t005
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effect on intention to test for both perceptions of individual responsibility vs bad luck and con-
trollable vs uncontrollable were still significantly different for pre-hypertension and CKD3A.
Discussion
By focussing on asymptomatic conditions and using an international sample we have
expanded the research on medical labelling. Previous “labelling” studies have focussed on
symptomatic conditions [5, 6] or on language such as various terminologies for papillary thy-
roid cancer [25], ductal carcinoma in situ [26] or bone fractures [27]. Overall, these studies
found an increased tendency to pursue further or more invasive testing when medical labels
or the term cancer were provided compared with a description of the symptoms only or lay
terminology. Contrary to these studies, we did not find a statistically significant difference
between participant’s intention to test scores when presented with either labelled or descriptive
only scenarios. The illnesses studied were specifically chosen because of recent diagnostic
threshold changes and the potential of overdiagnosis [8–11]. A greater number of individuals
are therefore likely to be classified as abnormal [12], and their potential inclination to pursue
further testing could strain health care systems. We advance several possible explanations why
our findings regarding intentions to pursue further testing differ.
In contrast to prior studies that explored symptomatic scenarios or the use of cancer termi-
nology, we compared label with description only scenarios for four different asymptomatic
health conditions (pre-hypertension, mild hyperlipidemia, pre-diabetes, and CKD 3A) and
participants were told their test results were “close to the threshold”. These conditions are com-
mon and thus potentially familiar to participants (aged 45+) who may have habituated to rou-
tine health checks and taking follow-up tests. Although individuals were randomly selected
in the age range most affected by the health conditions in the scenarios, our participants self-
reported as high users of health services and rated themselves highly on agreeableness and
conscientiousness, which may increase their testing practices. Their generally high scores on
the medical minimizer maximiser scale (mean = 4.6/7) suggests that participants preferred to
undertake interventions or medications they perceived positively and are biased toward action
rather than inaction or “watchful waiting” [18]. Interestingly, the average intention to test score
in the current study was 7.3 for description only compared with 7.1/10 for labelled scenarios.
This is higher than the intentions scores in the polycystic ovary syndrome study (6.6 and 5.8/10
in the label versus description condition) [6]. It may also be the case that given the age of partic-
ipants, some are familiar with and possibly taking medication for the conditions studied. We
did not ask participants about pre-existing health conditions or about familiarity of the health
condition assigned. We also did not control for socio-economic status and health literacy.
However, participants were randomly assigned to conditions, so it would be unlikely that levels
of familiarity, socio-economic status, and health literacy would systematically vary across con-
ditions. Participants were asked to imagine themselves as the recipient of the healthcare infor-
mation, however this is standard practice in these experimental designs. Individuals on
Qualtrics panels who are routinely exposed to surveys may also be more conscientious than
individuals randomly selected by other means.
Using participants from survey panels may introduce selection bias as participants are
reimbursed in some way for their time. However, reimbursing participants is common and
many studies have relied on recruitment agencies [e.g., 26, 28]. Recruiting participants in this
manner affords a broad geographical reach increasing the study’s generalisability and tests the
“labelling effect” with a large cross-cultural sample.
We used practitioner validated scenarios that also provided information on alternatives to test-
ing and information on overdiagnosis. However, these scenarios were not tested for literacy levels.
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For clarity and consistency, the scenarios were lengthy and worded similarly; however, by doing
this we may have provided too much information. Outside the medical domain, “information
overload” has been shown to lead to a reduction in decision making effort and quality [29].
In mediation analysis it is customary to have the manipulation and measure the effects of
interests, then measure potential effect modifiers. We reversed that order. We purposely posi-
tioned the psychological measures such as MMMS at the start of the survey because we wanted
participants to answer these without seeing the scenarios. However, because the characteristics
were health-related we may have inadvertently primed our participants to think about their
health which in turn may have impacted their responses.
We found that confidence and satisfaction in a person’s decision to undertake further tests
were both positively associated with increased intentions to test which held when adjusted for
labelling. These findings suggest that irrespective of whether the health condition was given a
medical label or not, those that were more prone to pursue further tests also felt more confi-
dent and satisfied with their decision. The lack of independence between intentions and confi-
dence/satisfaction is disconcerting and merits further research. It is reasonable to assume
clinicians would like their patients to be confident and satisfied with their decisions without
having to resort to increasingly active treatment.
Another unique element of this study included our exploration of risk perceptions and
effect modifiers. Although not statistically significant and we acknowledge that analyses at
the individual illness level are underpowered, the illustrative risk perception figure shows
that medical labels appear to evoke greater dread and concern compared with a description
of symptoms. This is consistent with a recent narrative synthesis of medical terminology [7]
where medicalised terms evoked greater perceived severity of the health condition. The emerg-
ing pattern in our risk perception figure generates new hypotheses about why this might be.
Prior labelling studies have not systematically investigated this issue using existing risk percep-
tion measures [22, 23] and what insights do exist are equivocal [7]. Insights revealed from
these exploratory analyses are therefore meant to stimulate follow-on research.
Finally, although other studies have found a significant difference between labelling and
description only scenarios in participants’ intention to test further, prior research has not sys-
tematically endeavored to unearth why. We found participants predisposed to seek health care
were more likely to test further as were those who perceived the health condition more con-
cerning and more likely attributable to personal responsibility.
Collectively these insights lead us to conclude that how medical labels affects health deci-
sion making is more nuanced than previous studies suggest. Unlike other studies, that pre-
sented participants with scenarios that either described the health condition or ascribed a
medical label [7], our results did not show a significant difference between these two scenar-
ios. Potentially, our choices of asymptomatic health conditions compared with symptomatic
conditions such as GERD [5] and PCOS [6] influenced these findings. Decisions made about
whether to undertake further tests the context of asymptomatic health conditions might dif-
fer from those made for symptomatic conditions. Here, we also found the ‘default option’ to
pursue further tests within this mature aged sample to be high; indeed, higher than in studies
involving symptoms. Given the aging demographics in all of three countries and the preva-
lence of the health conditions studied, this does not bode well for already stretched medical
facilities/budgets.
Practice implications
Good communication is the cornerstone of healthcare. To address the issues of overdiagnosis
and overtreatment and the burdens these create for individuals and the health care system, it is
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essential that health care professionals better understand how individuals respond to medical
labels, the psychological mechanisms that drive their decision-making, as well as whether
responses to asymptomatic health conditions differ from symptomatic ones. In this study,
nudging behaviour toward watchful waiting using different labels was not effective for the
asymptomatic illnesses studied.
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